{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:29:58Z","timestamp":1786984198615,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ajoc.2022.101618","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T21:38:18Z","timestamp":1656106698000},"page":"101618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Corneal thinning following bevacizumab intrastromal injection for the treatment of idiopathic lipid keratopathy"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-9064","authenticated-orcid":false,"given":"Kristie J.","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert S.","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6575-9160","authenticated-orcid":false,"given":"Kelley","family":"Bohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3827-2963","authenticated-orcid":false,"given":"Daniel","family":"Daroszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2022.101618_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000099253","article-title":"Immune privilege and angiogenic privilege of the cornea","volume":"92","author":"Cursiefen","year":"2007","journal-title":"Chem Immunol Allergy"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101618_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","article-title":"Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)","volume":"10","author":"Stevenson","year":"2012","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajoc.2022.101618_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s40123-020-00309-y","article-title":"Lipid keratopathy: a review of pathophysiology, differential diagnosis, and management","author":"Hall","year":"2020","journal-title":"Ophthalmol Ther"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101618_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcma.2014.10.002","article-title":"Corneal neovascularization and contemporary antiangiogenic therapeutics","volume":"78","author":"Hsu","year":"2015","journal-title":"J Chin Med Assoc"},{"issue":"7347","key":"10.1016\/j.ajoc.2022.101618_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ajoc.2022.101618_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1389450121666200319111710","article-title":"Anti-VEGF treatment in corneal diseases","volume":"21","author":"Giannaccare","year":"2020","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.ajoc.2022.101618_bib7","first-page":"1","article-title":"Intrastromal injection of bevacizumab in the management of corneal neovascularization: about 25 eyes","author":"Sarah","year":"2016","journal-title":"J Ophthalmol 2016"},{"key":"10.1016\/j.ajoc.2022.101618_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00417-019-04519-4","article-title":"Intrastromal bevacizumab in the management of corneal neovascularization: a retrospective review","volume":"258","author":"Gupta","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101618_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10792-014-9938-4","article-title":"Subconjunctival and\/or intrastromal bevacizumab injections as preconditioning therapy to promote corneal graft survival","volume":"35","author":"Fasciani","year":"2015","journal-title":"Int Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101618_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/ICO.0b013e3181e291a6","article-title":"Deep intrastromal bevacizumab injection for management of corneal stromal vascularization after deep anterior lamellar Keratoplasty, A novel technique","volume":"30","author":"Hashemian","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2022.101618_bib11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10792-013-9807-6","article-title":"Corneal endothelial safety following subconjunctival and intrastromal injection of bevacizumab for corneal neovascularization","volume":"34","author":"Lichtinger","year":"2014","journal-title":"Int Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajoc.2022.101618_bib12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1055\/s-2002-36944","article-title":"Prim\u00e4re lipidkeratopathie [primary lipid keratopathy]","volume":"219","author":"Spraul","year":"2002","journal-title":"Klin Monbl Augenheilkd"},{"issue":"10","key":"10.1016\/j.ajoc.2022.101618_bib13","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archopht.123.10.1435","article-title":"Unusual idiopathic lipid keratopathy: a newly recognized entity?","volume":"123","author":"Loeffler","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101618_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3174\/ajnr.A1987","article-title":"Bevacizumab (Avastin)","volume":"31","author":"Mukherji","year":"2010","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622003644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622003644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:03:49Z","timestamp":1762527829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993622003644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":14,"alternative-id":["S2451993622003644"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101618","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corneal thinning following bevacizumab intrastromal injection for the treatment of idiopathic lipid keratopathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101618"}}